Elevated expression of both mRNA and protein levels of IL-17A in sputum of stable Cystic Fibrosis patients
2010

IL-17A Levels in Cystic Fibrosis Patients

Sample size: 49 publication Evidence: moderate

Author Information

Author(s): Ann Decraene, Anna Willems-Widyastuti, Ahmad Kasran, Kris De Boeck, Dominique M Bullens, Lieven J Dupont

Primary Institution: KULeuven, Belgium

Hypothesis

IL-17A might be partly responsible for neutrophilic inflammation in the airways of cystic fibrosis patients.

Conclusion

Elevated levels of IL-17 and IL-23 suggest that Th17 cells are involved in the persistent neutrophil infiltration in cystic fibrosis lung disease.

Supporting Evidence

  • IL-17A protein and mRNA levels were significantly higher in CF patients compared to healthy controls.
  • Patients chronically infected with Pseudomonas aeruginosa had higher IL-17 and IL-23 mRNA levels.
  • No correlation was found between IL-17 or IL-23 levels and lung function (FEV1).

Takeaway

This study found that cystic fibrosis patients have higher levels of certain proteins that can cause inflammation in their lungs, which might make their condition worse.

Methodology

Sputum induction was performed in adult CF patients and healthy controls, followed by measurement of IL-17A protein and mRNA levels using cytometric bead array and quantitative RT-PCR.

Potential Biases

Potential selection bias as all recruited patients were adults with established lung disease.

Limitations

The study was limited to adult patients and did not include children or those with exacerbations.

Participant Demographics

38 stable adult CF patients and 11 healthy controls; mean age of CF patients was approximately 26 years.

Statistical Information

P-Value

p<0.0001

Statistical Significance

p<0.0001

Digital Object Identifier (DOI)

10.1186/1465-9921-11-177

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication